Home > PJ (current issue) > News / News Centre | Search

PJ Online homeThe Pharmaceutical Journal
Vol 272 No 7297 p533
1 May 2004

This article
Reprint   Photocopy

  Acrobat Reader


News summary


NHS may run out of vaccines, Parliamentary committee warns

Reliance on a small number of suppliers means that the NHS risks running out of many essential vaccines.

A House of Commons Public Accounts Committee report on vaccines procurement says that the Department of Health relies on just 10 suppliers for 16 essential vaccines. Only five of those vaccines are available from more than one supplier; two of them are available from three suppliers and three from only two suppliers.

“Limited competition, and near monopolistic conditions for supply of some vaccines, have made it more difficult to secure competitive prices and value for money,” the report says. “Furthermore, reliance on a single supplier has made the Department more vulnerable to interruptions in supply.”

The committee recognises that in most cases suppliers have delivered vaccines as required. But it notes that shortages of the measles, mumps and rubella vaccine (MMR) have occurred and that supplies of the anti-tuberculosis BCG vaccine once ran so short that the national vaccination programme was suspended for two years. Furthermore, it records that although the DoH monitors the supply and demand situation on a monthly basis, long lead times and increasing centralisation mean that international shortages could develop rapidly and that the DoH cannot guarantee that future shortages will not occur.

Back to Top


©The Pharmaceutical Journal